Clinical Trials Browser

Phase 1/2 × amrubicin × Clear all

NCT01033032 2022-05-03

Trial of Amrubicin as Treatment for Patients With HER2-Negative Metastatic Breast Cancer

Phase 1/2 Completed

78 enrolled 15 charts

Breast Neoplasms

NCT01355705 2018-09-18

Phase 1-2 Amrubicin in Combo With Lenalidomide + Weekly Dexamethasone in Relapsed/Refractory Multiple Myeloma

Phase 1/2 Completed

14 enrolled 9 charts

Multiple Myeloma